Single-chain antibody-mediated gene delivery into ErbB2-positive human breast cancer cells

Targeted gene transfer by nonviral vectors can be achieved through incorporation of specific ligand(s) into the vectors. In this study, the effects of incorporation of an anti-ErbB2 single-chain antibody fragment (ScFv) into nonviral vectors for targeted gene delivery were investigated. The ML39 ScFv, selected from a human ScFv phage display library and affinity matured in vitro ( K d=1×10−9 M), was used as ligand specific for the extracellular domain of the tumor surface protein, ErbB2. Two approaches were taken: (a) development of a vector that is composed of a bifunctional fusion protein capable of binding DNA with the ErbB2-specific ML39 ScFv at its N-terminus and a truncated form of human protamine at its C-terminus, and (b) formulation and evaluation of delivery vectors consisting of three independent components including ML39 ScFv, protamine, and cationic lipids. We demonstrate that fusion proteins comprised of the ML39 ScFv and a truncated form of protamine, denoted as ScFv-P-S, can selectively deliver exogenous DNA into ErbB2(+) cells, with an 8- to 10-fold increase in expression levels of the luciferase reporter gene in ErbB2(+) cells as compared to ErbB2(−) cells. In addition, vectors formulated by appropriately mixing DNA, ScFv, protamine, and lipids in vitro could even more efficiently deliver the reporter gene into ErbB2(+) cells with approximately 5-fold increase in gene expression in ErbB2(+) cell as compared to ErbB2(−) cells. Expression and refolding of the ScFv fusion proteins, in addition to determination of optimal conditions for vector development using these approaches, are discussed. Cancer Gene Therapy (2001) 8, 555–565

[1]  M. Cotten,et al.  Receptor-mediated endocytosis of transferrin-polycation conjugates: an efficient way to introduce DNA into hematopoietic cells. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[2]  M. Nango,et al.  Polycation liposomes, a novel nonviral gene transfer system, constructed from cetylated polyethylenimine , 2000, Gene Therapy.

[3]  J. Gerhart,et al.  Efficient construction of a large nonimmune phage antibody library: the production of high-affinity human single-chain antibodies to protein antigens. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[4]  F. Szoka,et al.  Branched cationic peptides for gene delivery: role of type and number of cationic residues in formation and in vitro activity of DNA polyplexes. , 1999, Human gene therapy.

[5]  L. Huang,et al.  In vivo gene transfer via intravenous administration of cationic lipid–protamine–DNA (LPD) complexes , 1997, Gene Therapy.

[6]  I. Pastan,et al.  A method for increasing the yield of properly folded recombinant fusion proteins: single-chain immunotoxins from renaturation of bacterial inclusion bodies. , 1992, Analytical biochemistry.

[7]  Curiel Dt,et al.  Strategies to achieve targeted gene delivery via the receptor-mediated endocytosis pathway. , 1994, Gene therapy.

[8]  J. Northrop,et al.  Lipofection: a highly efficient, lipid-mediated DNA-transfection procedure. , 1987, Proceedings of the National Academy of Sciences of the United States of America.

[9]  S. Simões,et al.  Gene delivery by negatively charged ternary complexes of DNA, cationic liposomes and transferrin or fusigenic peptides , 1998, Gene Therapy.

[10]  C R King,et al.  Improved binding and antitumor activity of a recombinant anti-erbB2 immunotoxin by disulfide stabilization of the Fv fragment. , 1994, The Journal of biological chemistry.

[11]  M. Cotten,et al.  Non-viral approaches to gene therapy. , 1993, Current opinion in biotechnology.

[12]  P. Cheng,et al.  Receptor ligand-facilitated gene transfer: enhancement of liposome-mediated gene transfer and expression by transferrin. , 1996, Human gene therapy.

[13]  I. Pastan,et al.  Recombinant Fv immunotoxins and Fv fragments as novel agents for cancer therapy and diagnosis. , 1998, Trends in biotechnology.

[14]  W. Wels,et al.  Target Cell-specific DNA Transfer Mediated by a Chimeric Multidomain Protein , 1996, The Journal of Biological Chemistry.

[15]  N. Brown.  Liposome advances: progress in drug and vaccine delivery, Fourth International CDDR Conference, 13–17 December 1999 , 2000, Gene Therapy.

[16]  G. Adams,et al.  Isolation of picomolar affinity anti-c-erbB-2 single-chain Fv by molecular evolution of the complementarity determining regions in the center of the antibody binding site. , 1996, Journal of molecular biology.

[17]  Y. Yarden,et al.  ErbB‐2 is a common auxiliary subunit of NDF and EGF receptors: implications for breast cancer. , 1996, The EMBO journal.

[18]  Leaf Huang,et al.  Folate-targeted, Anionic Liposome-entrapped Polylysine-condensed DNA for Tumor Cell-specific Gene Transfer (*) , 1996, The Journal of Biological Chemistry.

[19]  Tristan J. Vaughan,et al.  Human Antibodies with Sub-nanomolar Affinities Isolated from a Large Non-immunized Phage Display Library , 1996, Nature Biotechnology.

[20]  K. Peng,et al.  Viral vector targeting. , 1999, Current opinion in biotechnology.

[21]  Leaf Huang,et al.  Lipidic vector systems for gene transfer. , 1997, Critical reviews in therapeutic drug carrier systems.

[22]  A. Miller,et al.  An RGD-oligolysine peptide: a prototype construct for integrin-mediated gene delivery. , 1998, Human gene therapy.

[23]  J. C. Perales,et al.  Gene transfer into the airway epithelium of animals by targeting the polymeric immunoglobulin receptor. , 1995, The Journal of clinical investigation.

[24]  B. Groner,et al.  Retroviral targeted delivery. , 1996, Gene therapy.

[25]  N. Normanno,et al.  Epidermal growth factor-related peptides and their receptors in human malignancies. , 1995, Critical reviews in oncology/hematology.

[26]  Kuo-Fen Lee,et al.  Requirement for neuregulin receptor erbB2 in neural and cardiac development , 1995, Nature.

[27]  Hennie R. Hoogenboom,et al.  A Large Non-immunized Human Fab Fragment Phage Library That Permits Rapid Isolation and Kinetic Analysis of High Affinity Antibodies* , 1999, The Journal of Biological Chemistry.

[28]  C. Wu,et al.  Fate of DNA targeted to the liver by asialoglycoprotein receptor-mediated endocytosis in vivo. Prolonged persistence in cytoplasmic vesicles after partial hepatectomy. , 1993, The Journal of biological chemistry.

[29]  I. Pastan,et al.  A bivalent disulfide-stabilized Fv with improved antigen binding to erbB2. , 1998, Journal of molecular biology.

[30]  E. Chang,et al.  Transferrin-liposome-mediated systemic p53 gene therapy in combination with radiation results in regression of human head and neck cancer xenografts. , 1999, Human gene therapy.

[31]  N. Hynes,et al.  The biology of erbB-2/neu/HER-2 and its role in cancer. , 1994, Biochimica et biophysica acta.

[32]  D. Curiel,et al.  Strategies to achieve targeted gene delivery via the receptor-mediated endocytosis pathway. , 1994, Gene therapy.

[33]  J. C. Perales,et al.  Gene transfer in vivo: sustained expression and regulation of genes introduced into the liver by receptor-targeted uptake. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[34]  W. Wels,et al.  A Modular DNA Carrier Protein Based on the Structure of Diphtheria Toxin Mediates Target Cell-specific Gene Delivery* , 1998, The Journal of Biological Chemistry.

[35]  M. Westerfield,et al.  Characterization of paired tumor and non‐tumor cell lines established from patients with breast cancer , 1998, International journal of cancer.

[36]  W. Marasco,et al.  Design of a genetic immunotoxin to eliminate toxin immunogenicity. , 1995, Gene therapy.

[37]  L. Huang,et al.  Protamine sulfate enhances lipid-mediated gene transfer , 1997, Gene Therapy.

[38]  M. Cotten,et al.  Transferrin-polycation-DNA complexes: the effect of polycations on the structure of the complex and DNA delivery to cells. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[39]  W. Marasco,et al.  Paramagnetic proteoliposomes containing a pure, native, and oriented seven-transmembrane segment protein, CCR5 , 2000, Nature Biotechnology.

[40]  P. Felgner.  Improvements in cationic liposomes for in vivo gene transfer. , 1996, Human gene therapy.

[41]  C. Wu,et al.  Receptor-mediated gene delivery and expression in vivo. , 1988, The Journal of biological chemistry.